A Rare Case of Opsoclonus Myoclonus Ataxia Syndrome Post Viral Illness.

dancing eyes-dancing feet syndrome gait ataxia kinsbourne syndrome opsoclonus myoclonus opsoclonus myoclonus ataxia syndrome post-viral syndrome

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2023
Historique:
accepted: 13 06 2023
medline: 17 7 2023
pubmed: 17 7 2023
entrez: 17 7 2023
Statut: epublish

Résumé

Opsoclonus myoclonus ataxia syndrome (OMAS) is a rare inflammatory neurological disorder characterized by ocular, motor, behavioral, language, and sleep disturbances. It usually affects infants and young children but may affect adults. A 28-year-old male was brought to our emergency ward with complaints of involuntary spontaneous eye movements and jerky movements of limbs with imbalance while walking. He had a history of short febrile illness 10 days prior. His magnetic resonance imaging (MRI) of the brain, cerebrospinal fluid (CSF) analysis, and other routine investigations were normal. The patient was treated with injectable methylprednisolone (1 g) given for five days along with other supportive therapy. A significant reduction in the opsoclonus, myoclonus, and ataxia was seen on a six-month follow-up. OMAS should be identified early to avoid the use of inappropriate medications, and immunotherapy must be provided as early as possible in order to prevent irreversible neurological damage.

Identifiants

pubmed: 37456490
doi: 10.7759/cureus.40396
pmc: PMC10345879
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e40396

Informations de copyright

Copyright © 2023, Shah et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Mov Disord. 1995 Jan;10(1):22-7
pubmed: 7885352
JAMA Neurol. 2016 Apr;73(4):417-24
pubmed: 26856612
J Pediatr. 1997 Jun;130(6):878-84
pubmed: 9202608
J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):279-80
pubmed: 12531974
Arch Neurol. 2012 Dec;69(12):1598-607
pubmed: 22986354
Clin Neuropharmacol. 1992 Jun;15(3):186-228
pubmed: 1394242
Pediatr Neurol. 2006 Sep;35(3):213-5
pubmed: 16939863
Clin Neurol Neurosurg. 2008 Jun;110(6):619-21
pubmed: 18433986
Pediatrics. 2011 Aug;128(2):e388-94
pubmed: 21788225
J Neurol. 2019 Jun;266(6):1541-1548
pubmed: 30483882
JAMA Neurol. 2016 Apr;73(4):381-2
pubmed: 26856251
Lancet Child Adolesc Health. 2018 Jan;2(1):25-34
pubmed: 29376112
Indian Pediatr. 2011 Aug;48(8):627-32
pubmed: 21918268
J Child Neurol. 2009 Mar;24(3):316-22
pubmed: 19258290
Pediatrics. 2002 Jan;109(1):86-98
pubmed: 11773546

Auteurs

Nauka S Shah (NS)

Department of Medicine, Baroda Medical College, Maharaja Sayajirao (MS) University, Vadodara, IND.

Jaya Pathak (J)

Department of Internal Medicine, Baroda Medical College, Maharaja Sayajirao (MS) University, Vadodara, IND.

Purva C Shah (PC)

Department of Internal Medicine, Baroda Medical College, Maharaja Sayajirao (MS) University, Vadodara, IND.

Ummayhany F Bharmal (UF)

Department of Medicine, Baroda Medical College, Maharaja Sayajirao (MS) University, Vadodara, IND.

Maliha I Ansari (MI)

Department of Internal Medicine, Pramukhswami Medical College, Anand, IND.

Classifications MeSH